February 12, 2018

Belinda Ostrowsky, Ritu Banerjee, Robert A Bonomo, Sara E Cosgrove, Lisa Davidson, Shira Doron, David N Gilbert, Amanda Jezek, John B Lynch, III, Edward J Septimus, Javeed Siddiqui, and Nicole M Iovine
Clinical Infectious Diseases, Volume 66, Issue 7, 1 April 2018, Pages 995–1003, https://doi.org/10.1093/cid/cix1093

Abstract

Antimicrobial resistance is a well-documented public health crisis that seriously threatens patient outcomes and national security. Further, the World Health Organization has recognized antimicrobial resistance as a threat to global stability [1]. The overuse and misuse of antimicrobial agents are key drivers of the development of resistance. Antimicrobial stewardship programs (ASPs) optimize patient outcomes while minimizing unintended consequences of antimicrobial use. Antimicrobial stewardship has been defined as “coordinated interventions designed to improve and measure the appropriate use of antimicrobial agents by promoting the selection of the optimal antimicrobial drug regimen including dosing, duration of therapy, and route of administration.” [2] Given new regulatory requirements and political support for stewardship, healthcare facilities will…

Source: https://academic.oup.com/cid/article-abstract/66/7/995/4851152?redirectedFrom=fulltext